EP0491812A4 - Drug delivery compositions - Google Patents

Drug delivery compositions

Info

Publication number
EP0491812A4
EP0491812A4 EP19900914097 EP90914097A EP0491812A4 EP 0491812 A4 EP0491812 A4 EP 0491812A4 EP 19900914097 EP19900914097 EP 19900914097 EP 90914097 A EP90914097 A EP 90914097A EP 0491812 A4 EP0491812 A4 EP 0491812A4
Authority
EP
European Patent Office
Prior art keywords
drug delivery
delivery compositions
compositions
drug
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900914097
Other versions
EP0491812A1 (en
Inventor
Clive Frederick Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australia Commercial Research and Development Ltd
Original Assignee
Australia Commercial Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Australia Commercial Research and Development Ltd filed Critical Australia Commercial Research and Development Ltd
Publication of EP0491812A1 publication Critical patent/EP0491812A1/en
Publication of EP0491812A4 publication Critical patent/EP0491812A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19900914097 1989-09-14 1990-09-14 Drug delivery compositions Withdrawn EP0491812A4 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AUPJ635689 1989-09-14
AU6355/89 1989-09-14
AUPJ635589 1989-09-14
AU6356/89 1989-09-14
AUPJ691389 1989-10-17
AU6913/89 1989-10-17

Publications (2)

Publication Number Publication Date
EP0491812A1 EP0491812A1 (en) 1992-07-01
EP0491812A4 true EP0491812A4 (en) 1992-11-04

Family

ID=27157526

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900914097 Withdrawn EP0491812A4 (en) 1989-09-14 1990-09-14 Drug delivery compositions

Country Status (2)

Country Link
EP (1) EP0491812A4 (en)
WO (1) WO1991004026A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251615B (en) * 1991-10-04 1995-05-17 Golgi Sa ANTIELASTASIC ACTIVITY MEDICATION.
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
TW293036B (en) * 1992-11-27 1996-12-11 Takeda Pharm Industry Co Ltd
JPH06157330A (en) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd Cyclodextrin clathrate of taxol, it production and use thereof
US5840881A (en) * 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
DE69425948T2 (en) * 1993-12-06 2001-02-22 Takeda Chemical Industries Ltd Composition with improved water solubility, containing a water-insoluble or water-insoluble compound
FR2713934B1 (en) * 1993-12-22 1996-01-12 Commissariat Energie Atomique Use of amino cyclodextrins for the aqueous solubilization of hydrophobic compounds, in particular of pharmaceutically active molecules.
JPH10500982A (en) * 1994-05-27 1998-01-27 ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ Pharmaceutical composition
US5785995A (en) * 1997-04-11 1998-07-28 Upsher-Smith Laboratories, Inc. Pharmaceutical tablet of amiodarone salt
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
KR101037313B1 (en) * 2002-09-05 2011-05-26 바라트 쎄럼스 앤드 백신스 리미티드 Liquid Stable Composition of Oxazaphosphorine with Mesna
EA012368B1 (en) * 2002-12-02 2009-10-30 Бхарат Сирумс Энд Вэксинс Лтд. Ifosfamide compositions for parenteral administration and process for their preparation
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CA2763365C (en) 2009-05-29 2016-09-13 Cydex Pharmaceuticals, Inc. Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
CN103079559A (en) * 2010-06-11 2013-05-01 巴克斯特国际公司 Formulations including amiodarone and salts thereof and methods of their manufacture and use
WO2020084572A1 (en) * 2018-10-24 2020-04-30 Adama Makhteshim Ltd. Use of cyclodextrins as agrochemical delivery system
EP3906263A4 (en) 2019-01-03 2022-08-31 Underdog Pharmaceuticals, Inc. Cyclodextrin dimers, compositions thereof, and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293537A1 (en) * 1986-12-26 1988-12-07 Nisshin Flour Milling Co., Ltd. Sustained release drug preparation
WO1990009171A1 (en) * 1989-02-20 1990-08-23 Soorianarain Baligadoo Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541077A (en) * 1968-05-31 1970-11-17 Cpc International Inc Method of preparing pure alpha-cyclodextrin
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
HU199444B (en) * 1985-09-10 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom
NZ225045A (en) * 1987-07-01 1990-06-26 Janssen Pharmaceutica Nv Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
ES2058503T5 (en) * 1988-03-29 1999-04-16 Univ Florida PHARMACEUTICAL FORMULATIONS FOR PARENTERAL USE.
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293537A1 (en) * 1986-12-26 1988-12-07 Nisshin Flour Milling Co., Ltd. Sustained release drug preparation
WO1990009171A1 (en) * 1989-02-20 1990-08-23 Soorianarain Baligadoo Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
See also references of WO9104026A1 *
THE MERCK INDEX, 10th ed., Merck & Co. Ltd., 1983, Rahway, NJ (US); E. WINDHOLZ et al., pp. 72-73# *
THE MERCK INDEX, tenth edition, Ed. Windholz et al., 1983, pages 72-73, Merck & Co., Inc., Rahway, N.J. US *

Also Published As

Publication number Publication date
WO1991004026A1 (en) 1991-04-04
EP0491812A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
GB9025491D0 (en) Pharmaceutical compositions
EP0491812A4 (en) Drug delivery compositions
ZA901348B (en) Pharmaceutical compositions
GB8909022D0 (en) Pharmaceutical compositions
ZA905511B (en) Pharmaceutical compositions
GB2232891B (en) Pharmaceutical composition
HUT56269A (en) Pharmaceutical compositions
GB9015436D0 (en) Pharmaceutical compositions
GB8909906D0 (en) Pharmaceutical compositions
GB8922130D0 (en) Pharmaceutical compositions
GB8916069D0 (en) Pharmaceutical compositions
GB8919447D0 (en) Pharmaceutical compositions
GB8916070D0 (en) Pharmaceutical compositions
IE892802L (en) Pharmaceutical compositions
GB8917287D0 (en) Pharmaceutical compositions
GB8914099D0 (en) Pharmaceutical compositions
IE892803L (en) Pharmaceutical compositions
GB8927109D0 (en) Pharmaceutical compositions
IE894216L (en) Pharmaceutical compositions
IL89935A0 (en) Pharmaceutical compositions
GB8919130D0 (en) Pharmaceutical compositions
GB8922149D0 (en) Pharmaceutical compositions
IE891521L (en) Pharmaceutical compositions
GB8919446D0 (en) Pharmaceutical compositions
GB8915044D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920313

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19920911

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950331